Skip to main content
. 2018 Feb 27;33(1):546–557. doi: 10.1080/14756366.2018.1437729

Figure 1.

Figure 1.

Reported and proposed pyrido[2,3-d]pyrimidine conjugates with anticancer and tyrosine kinase inhibitory activity.